Microbix Biosystems (TSE:MBX) Stock Breaks Above Fifty Day Moving Average – Time to Sell?

Microbix Biosystems Inc. (TSE:MBX)’s share price passed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of C$0.30 and traded as high as C$0.30. Microbix Biosystems shares last traded at C$0.30, with a volume of 15,050 shares.

Microbix Biosystems Stock Down 1.6%

The firm’s 50-day simple moving average is C$0.30 and its 200-day simple moving average is C$0.28. The company has a debt-to-equity ratio of 27.69, a quick ratio of 5.57 and a current ratio of 6.89. The company has a market capitalization of C$41.09 million, a price-to-earnings ratio of -8.33 and a beta of 0.61.

Microbix Biosystems (TSE:MBX) last released its quarterly earnings data on Thursday, August 13th. The company reported C($0.01) earnings per share (EPS) for the quarter. Microbix Biosystems had a negative net margin of 31.72% and a negative return on equity of 18.83%. The firm had revenue of C$4.06 million for the quarter. Sell-side analysts forecast that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

Microbix Biosystems Company Profile

Microbix Biosystems Inc creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.